Cargando…
Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis
Cisplatin is widely used in the treatment of solid tumors, but its application is greatly limited due to its nephrotoxicity; thus, there is still no effective medicine for the treatment of cisplatin-induced acute kidney injury (Cis-AKI). We previously identified that polydatin (PD) exerts nephroprot...
Autores principales: | Zhou, Lu, Yu, Peng, Wang, Ting-ting, Du, Yi-wei, Chen, Yang, Li, Zhen, He, Man-lin, Feng, Lan, Li, Hui-rong, Han, Xiao, Ma, Heng, Liu, Hong-bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783728/ https://www.ncbi.nlm.nih.gov/pubmed/35075382 http://dx.doi.org/10.1155/2022/9947191 |
Ejemplares similares
-
Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury via SIRT6-Mediated Autophagy Activation
por: Li, Zhen, et al.
Publicado: (2022) -
Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation
por: He, Manlin, et al.
Publicado: (2022) -
Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway
por: Du, Yi-Wei, et al.
Publicado: (2023) -
Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice
por: Li, Rui, et al.
Publicado: (2018) -
VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis
por: Hu, Zhaoxin, et al.
Publicado: (2020)